|
GB587992A
(en)
|
1944-12-11 |
1947-05-12 |
Charles William Scaife |
Improvements in and relating to the production of organic nitrogen compounds
|
|
US3578687A
(en)
|
1968-01-30 |
1971-05-11 |
Texaco Inc |
Process for producing 4-nitroalkanoic acids
|
|
US3819561A
(en)
|
1970-10-23 |
1974-06-25 |
Aerojet General Co |
Wetting agents for non-aqueous dispersions
|
|
JPS5313608B2
(da)
|
1972-06-16 |
1978-05-11 |
|
|
|
JPS5318013B2
(da)
|
1973-03-19 |
1978-06-13 |
|
|
|
US4599430A
(en)
|
1981-12-21 |
1986-07-08 |
The Standard Oil Company |
Nitrogenation of hydrocarbons, including the production of maleimide
|
|
JPS62132804A
(ja)
|
1985-12-05 |
1987-06-16 |
Aguro Kanesho Kk |
植物生長調節剤
|
|
US5412137A
(en)
|
1993-06-07 |
1995-05-02 |
Sandoz Ltd. |
Process for preparing phosphinyloxy propanaminium inner salt derivatives
|
|
AU2989695A
(en)
|
1994-08-08 |
2000-03-07 |
Debiopharm S.A. |
Pharmaceutically stable oxaliplatinum preparation
|
|
CN1088058C
(zh)
|
1994-10-13 |
2002-07-24 |
肽技术有限公司 |
经修饰的多不饱和脂肪酸
|
|
US5919816A
(en)
|
1994-11-14 |
1999-07-06 |
Bionumerik Pharmaceuticals, Inc. |
Formulations and methods of reducing toxicity of antineoplastic agents
|
|
US5741211A
(en)
|
1995-10-26 |
1998-04-21 |
Medtronic, Inc. |
System and method for continuous monitoring of diabetes-related blood constituents
|
|
GB9618420D0
(en)
|
1996-09-04 |
1996-10-16 |
Scotia Holdings Plc |
Fatty acid treatment
|
|
US6187747B1
(en)
|
1997-09-08 |
2001-02-13 |
Panacea Biotech Limited |
Pharmaceutical composition comprising cyclosporin
|
|
GB9722520D0
(en)
|
1997-10-24 |
1997-12-24 |
Pfizer Ltd |
Compounds
|
|
JP4309045B2
(ja)
|
1997-10-30 |
2009-08-05 |
森下仁丹株式会社 |
不飽和脂肪酸またはその誘導体を内容物とするカプセル製剤およびその製造法
|
|
HU227841B1
(en)
|
1997-11-12 |
2012-05-02 |
Bayer Pharma AG |
2-phenyl substituted imidazotriazinones, process for their preparation and pharmaceutical compositions thereof
|
|
US7795246B2
(en)
|
1998-08-06 |
2010-09-14 |
Cephalon, Inc. |
Particle-forming compositions containing fused pyrrolocarbazoles
|
|
US6262029B1
(en)
|
1998-08-14 |
2001-07-17 |
Galenica Pharmaceuticals, Inc. |
Chemically modified saponins and the use thereof as adjuvants
|
|
KR20010101603A
(ko)
|
1999-01-20 |
2001-11-14 |
노왈드 |
이미다조[1,5-ａ]-피리도[3,2-ｅ]-피라지논의 약제로서의용도
|
|
US6459003B1
(en)
|
1999-04-01 |
2002-10-01 |
Esperion Therapeutics, Inc. |
Ether compounds
|
|
AU5319499A
(en)
|
1999-07-22 |
2001-02-13 |
Ivan L. Cameron |
Fatty acids to minimize cancer therapy side effects
|
|
SE9903028D0
(sv)
|
1999-08-27 |
1999-08-27 |
Astra Ab |
New use
|
|
AUPQ291499A0
(en)
|
1999-09-17 |
1999-10-07 |
Women's And Children's Hospital Adelaide |
Novel nitro and sulphur containing compounds
|
|
US6346231B1
(en)
|
1999-10-06 |
2002-02-12 |
Joar Opheim |
Flavored gelatin capsule and method of manufacture
|
|
IL139455A0
(en)
|
1999-11-08 |
2001-11-25 |
Pfizer |
Compounds for the treatment of female sexual dysfunction
|
|
US20010037598A1
(en)
|
1999-12-14 |
2001-11-08 |
Suppes Galen J. |
Process for producing cetane improvers from triglycerides
|
|
IL151299A0
(en)
|
2000-02-16 |
2003-04-10 |
Brigham & Womens Hospital |
Aspirin-triggered lipid mediators
|
|
AR034120A1
(es)
|
2000-04-13 |
2004-02-04 |
Pharmacia Corp |
Compuesto derivado halogenado del acido 2-amino-4,5 heptenoico, composicion farmaceutica que lo comprende y el uso de dicho compuesto y dicha composicion en la fabricacion de un medicamento para inhibir o modular la sintesis de acido nitrico
|
|
AR032318A1
(es)
|
2000-04-13 |
2003-11-05 |
Pharmacia Corp |
Compuesto derivado halogenado del acido 2-amino-5,6 heptenoico; composicion farmaceutica que lo comprende y su uso en la fabricacion de un medicamento util como inhibidor de la oxido nitrico sintetasa
|
|
AR030416A1
(es)
|
2000-04-13 |
2003-08-20 |
Pharmacia Corp |
COMPUESTO DERIVADO HALOGENADO DEL ACIDO 2-AMINO-3,4 HEPTENOICO, COMPOSICION FARMACEUTICA QUE LO COMPRENDE Y SU USO EN LA FABRICACION DE UN MEDICAMENTO uTIL COMO INHIBIDOR DE LA OXIDO NITRICO SINTETASA
|
|
CN1232480C
(zh)
|
2000-06-28 |
2005-12-21 |
萨宝集团公司 |
制备硝基烯烃的方法
|
|
AR031129A1
(es)
|
2000-09-15 |
2003-09-10 |
Pharmacia Corp |
Derivados de los acidos 2-amino-2-alquil-4-hexenoico y -hexinoico utiles como inhibidores de oxido nitrico sintetasa
|
|
EP1368022B1
(fr)
|
2001-03-02 |
2007-06-20 |
Debiopharm S.A. |
Utilisation d'un flacon contenant une solution d'oxaliplatine
|
|
DK1900364T3
(da)
|
2001-04-18 |
2014-01-13 |
Prometic Biosciences Inc |
Fedtsyrer, glycerider og analoger med medium kædelængde som neutrofile overlevelses- og aktiveringsfaktorer
|
|
US7105556B2
(en)
|
2001-05-30 |
2006-09-12 |
Bristol-Myers Squibb Company |
Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method
|
|
US20040176451A1
(en)
|
2001-06-18 |
2004-09-09 |
Tadakazu Tamai |
Pparg agonistic medicinal compositions
|
|
JP2005501096A
(ja)
|
2001-08-17 |
2005-01-13 |
ユニヴァーシティ オブ ピッツバーグ |
肥満、代謝症候群、糖尿病、血管障害及び腎臓疾患を治療又は予防するエストラジオールメタボライトの投与
|
|
GB0123961D0
(en)
|
2001-10-05 |
2001-11-28 |
Astrazeneca Ab |
Process and intermediates
|
|
KR20040053210A
(ko)
|
2001-11-02 |
2004-06-23 |
화이자 프로덕츠 인크. |
Ｐｄｅ9 억제제를 사용한 인슐린 저항 증후군 및 2형당뇨병의 치료
|
|
HN2002000317A
(es)
|
2001-11-02 |
2003-05-21 |
Pfizer |
Inhibidores de pde9 para tratamiento de trastornos cardiovasculares
|
|
CA2465117C
(en)
|
2001-11-06 |
2012-01-03 |
Brigham And Women's Hospital, Inc. |
Lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases
|
|
GB2388111A
(en)
|
2002-05-01 |
2003-11-05 |
Bayer Ag |
Novel imidazotriazinone compounds
|
|
US6684626B1
(en)
|
2002-07-30 |
2004-02-03 |
General Electric Company |
Aircraft gas turbine engine with control vanes for counter rotating low pressure turbines
|
|
US7759395B2
(en)
|
2002-08-12 |
2010-07-20 |
The Brigham And Women's Hospital, Inc. |
Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma
|
|
US20060100278A1
(en)
|
2002-08-20 |
2006-05-11 |
Cooper Garth J S |
Dosage forms and related therapies
|
|
EP1558237A4
(en)
|
2002-09-27 |
2007-01-17 |
Martek Biosciences Corp |
IMPROVED BLOOD SUGAR CONTROL F RPRU-DIABETES AND / OR DIABETES TYPE II USING DOCOSAHEXAENSURE
|
|
US7326421B2
(en)
|
2002-10-21 |
2008-02-05 |
Kensey Nash Corporation |
Device and methods for sequential, regional delivery of multiple cytotoxic agents and directed assembly of wound repair tissues
|
|
US7166575B2
(en)
|
2002-12-17 |
2007-01-23 |
Nastech Pharmaceutical Company Inc. |
Compositions and methods for enhanced mucosal delivery of peptide YY and methods for treating and preventing obesity
|
|
US20040220186A1
(en)
|
2003-04-30 |
2004-11-04 |
Pfizer Inc. |
PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
|
|
WO2005016864A1
(en)
|
2003-07-29 |
2005-02-24 |
The Arizona Disease Control Research Commission |
Conjugated nitro alkene anticancer agents based on isoprenoid metabolism
|
|
US20050136103A1
(en)
|
2003-09-17 |
2005-06-23 |
Ben-Sasson Shmuel A. |
Compositions capable of facilitating penetration across a biological barrier
|
|
US7935365B2
(en)
|
2003-10-22 |
2011-05-03 |
Enzymotec, Ltd. |
Glycerophospholipids for the improvement of cognitive functions
|
|
BRPI0416118A
(pt)
|
2003-10-31 |
2007-01-02 |
Pfizer Prod Inc |
inibição da fosfodiesterase 9 como tratamento para estados relacionados com a obesidade
|
|
JP2007522118A
(ja)
|
2004-01-30 |
2007-08-09 |
ペプリン バイオリピッズ ピーティーワイ エルティーディー |
治療用分子および担体分子
|
|
CA2563533C
(en)
|
2004-04-15 |
2013-10-01 |
Shmuel A. Ben-Sasson |
Compositions capable of facilitating penetration across a biological barrier
|
|
WO2005110396A2
(en)
|
2004-04-28 |
2005-11-24 |
Uab Research Foundation |
Nitrated lipids and methods of making and using thereof
|
|
CN101027318B
(zh)
|
2004-07-19 |
2016-05-25 |
比奥孔有限公司 |
胰岛素-低聚物共轭物，制剂及其用途
|
|
MY139689A
(en)
|
2004-07-20 |
2009-10-30 |
Osi Pharm Inc |
Imidazotriazines as protein kinase inhibitors
|
|
EP1772149A1
(en)
|
2004-07-27 |
2007-04-11 |
Kowa Company. Ltd. |
Drug for prevention or treatment of diabetes
|
|
CA2588166A1
(en)
|
2004-11-19 |
2006-05-26 |
Martek Biosciences Corporation |
Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same
|
|
EP1817009A2
(en)
|
2004-11-24 |
2007-08-15 |
Spi Pharma, Inc. |
Orally disintegrating compositions
|
|
AU2011202664B2
(en)
|
2004-12-08 |
2012-04-05 |
Cedars-Sinai Medical Center |
Methods for diagnosis and treatment of Crohn's disease
|
|
US20070032420A1
(en)
|
2005-02-09 |
2007-02-08 |
Entelos, Inc. |
Treating diabetes with glucagon-like peptide-1 secretagogues
|
|
EP1928237A4
(en)
|
2005-09-02 |
2011-03-09 |
Abbott Lab |
NEW HETEROCYCLES BASED ON IMIDAZO
|
|
GB0522569D0
(en)
|
2005-11-04 |
2005-12-14 |
Univ Bath |
Biocompatible drug delivery device
|
|
TW200815436A
(en)
|
2006-05-30 |
2008-04-01 |
Elbion Ag |
4-amino-pyrido[3,2-e]pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them
|
|
US9274129B2
(en)
|
2006-05-31 |
2016-03-01 |
Lpath, Inc. |
Methods and reagents for detecting bioactive lipids
|
|
WO2008008767A2
(en)
|
2006-07-14 |
2008-01-17 |
Cedars-Sinai Medical Center |
Methods of using ppar-gamma agonists and caspase-dependent chemotherapeutic agents for the treatment of cancer
|
|
BRPI0714562A2
(pt)
|
2006-07-19 |
2013-04-02 |
Resolvyx Pharmaceuticals Inc |
composiÇÕes e mÉtodos para o tratamento de mucosites
|
|
WO2008029589A1
(en)
|
2006-09-08 |
2008-03-13 |
Tokuyama Corporation |
Method and equipment for producing group-iii nitride
|
|
AU2007332439A1
(en)
*
|
2006-12-13 |
2008-06-19 |
Aska Pharmaceutical Co., Ltd. |
Therapeutic agent for urinary tract disease
|
|
WO2008072779A1
(ja)
|
2006-12-13 |
2008-06-19 |
Aska Pharmaceutical Co., Ltd. |
キノキサリン誘導体
|
|
EP2120920A4
(en)
|
2007-02-20 |
2011-06-15 |
Martek Biosciences Corp |
OXYLIPINES OF LONG-CHAIN MULTIPLE-UNSATURATED FATTY ACIDS AND METHOD FOR THEIR PREPARATION AND USE
|
|
PT2152712E
(pt)
|
2007-05-11 |
2012-02-29 |
Pfizer |
Compostos amino-heterocíclicos
|
|
DE102007032349A1
(de)
|
2007-07-11 |
2009-01-15 |
Bayer Healthcare Ag |
Imidazo-, Pyrazolopyrazine und Imidazotriazine und ihre Verwendung
|
|
EP2679224A1
(en)
|
2007-08-01 |
2014-01-01 |
University of Pittsburgh of the Commonwealth System of Higher Education |
Nitro oleic acid modulation of type II diabetes
|
|
EP2207543A2
(en)
|
2007-09-14 |
2010-07-21 |
Resolvyx Pharmaceuticals, Inc. |
Omega-3 fatty acids, hydroxy polyunsaturated fatty acids, lipoxin compounds, or oxylipin compounds for treating autoimmune diseases or inhibiting immune function
|
|
US20110092594A1
(en)
|
2008-04-18 |
2011-04-21 |
Tianxin Yang |
Use of nitrated lipids for treatment of lipid disorders and obesity, and lipid- and obesity-related conditions
|
|
DK2280928T3
(da)
|
2008-05-01 |
2018-11-05 |
Complexa Inc |
Vinylsubstituerede fedtsyrer
|
|
WO2009149496A1
(en)
|
2008-06-10 |
2009-12-17 |
Central Northern Adelaide Health Service |
Treatment of diabetes and complications thereof and related disorders
|
|
CN102099024B
(zh)
|
2008-06-19 |
2015-11-25 |
犹他大学研究基金会 |
硝化脂质在毒性医疗疗法的副作用的治疗上的用途
|
|
US20140024713A1
(en)
|
2008-06-19 |
2014-01-23 |
University Of Utah Research Foundation |
Use of nitrated lipids for treatment of side effects of toxic medical therapies
|
|
ES2622559T3
(es)
|
2008-07-29 |
2017-07-06 |
Nerviano Medical Sciences S.R.L. |
Combinación terapéutica que comprende un inhibidor de cdk y un agente antineoplásico
|
|
AU2009303345B2
(en)
|
2008-10-09 |
2015-08-20 |
Arbutus Biopharma Corporation |
Improved amino lipids and methods for the delivery of nucleic acids
|
|
JP2012513774A
(ja)
|
2008-12-31 |
2012-06-21 |
ニトロメガ コーポレーション |
ニトロ脂肪酸を含有する栄養補助物
|
|
US8937194B2
(en)
|
2008-12-31 |
2015-01-20 |
Nitromega Corp. |
Topical compositions containing nitro fatty acids
|
|
TWI404721B
(zh)
|
2009-01-26 |
2013-08-11 |
Pfizer |
胺基－雜環化合物
|
|
US20100286271A1
(en)
|
2009-05-08 |
2010-11-11 |
Perricone Nicholas V |
Nitro-alkyl Compound Compositions
|
|
US20100286257A1
(en)
|
2009-05-08 |
2010-11-11 |
Perricone Nicholas V |
Methods Of Use Of Nitroalkane Compositions In Dermatologic Applications To Prevent or Treat Skin Aging
|
|
US20100286272A1
(en)
|
2009-05-08 |
2010-11-11 |
Perricone Nicholas V |
Methods Of Use Of Nitroalkene Compositions In Dermatologic Applications
|
|
EP2456311A4
(en)
|
2009-07-24 |
2013-01-23 |
Concert Pharmaceuticals Inc |
SUBSTITUTED IMIDASOTRIAZINES
|
|
KR20120046754A
(ko)
|
2009-07-29 |
2012-05-10 |
페노미넘 디스커버리스 인코포레이티드 |
히드록시 지방산 화합물 및 질병 치료 및 진단을 위한 그의 용도
|
|
CA2769624C
(en)
|
2009-07-31 |
2018-09-11 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Electrophilic fatty acid derivatives as anti-inflammatory agents
|
|
WO2011028820A1
(en)
|
2009-09-02 |
2011-03-10 |
Concert Pharmaceuticals, Inc. |
Substituted derivatives of bicyclic [4.3.0] heteroaryl compounds
|
|
WO2011030351A2
(en)
|
2009-09-03 |
2011-03-17 |
Rubicon Research Private Limited |
Taste - masked pharmaceutical compositions
|
|
WO2011041639A2
(en)
|
2009-10-02 |
2011-04-07 |
Miller Raymond A |
Heteroatom containing substituted fatty acids
|
|
US20130005730A1
(en)
|
2009-11-09 |
2013-01-03 |
Piaoyang Sun |
Novel 1,3-oxazolidine compounds and their use as renin inhibitors
|
|
WO2011098746A1
(en)
|
2010-02-09 |
2011-08-18 |
Pulmagen Therapeutics (Inflammation) Limited |
Crystalline acid addition salts of ( 5r) -enanti0mer of pioglitazone
|
|
WO2011113507A2
(en)
|
2010-03-15 |
2011-09-22 |
Ulrich Dietz |
Use of nitrocarboxylic acids for the treatment, diagnosis and prophylaxis of aggressive healing patterns
|
|
BR112012027915A2
(pt)
|
2010-05-13 |
2018-10-23 |
Nitromega Corp |
nitro-ácidos graxos - neuroproteção e/ou inibição do declínio cognitivo
|
|
EP2590643A4
(en)
|
2010-06-28 |
2014-01-01 |
Complexa Inc |
MEDICINAL PRODUCT MADE FROM SEVERAL INGREDIENTS FOR THE TREATMENT OF DIABETES
|
|
EP3181566A1
(en)
|
2010-09-20 |
2017-06-21 |
Ironwood Pharmaceuticals, Inc. |
Imidazotriazinone compounds
|
|
US8809345B2
(en)
|
2011-02-15 |
2014-08-19 |
Boehringer Ingelheim International Gmbh |
6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders
|
|
EP2744491B1
(en)
|
2011-08-19 |
2020-07-29 |
The University of Utah Research Foundation |
Combination therapy with nitrated lipids and inhibitors of the renin-angiotensin-aldosterone system
|
|
CN103930423B
(zh)
|
2011-10-07 |
2015-09-16 |
卫材Rd管理有限公司 |
吡唑并喹啉衍生物
|
|
MX381326B
(es)
*
|
2011-10-10 |
2025-03-12 |
H Lundbeck As |
Derivados de 7h-imidazo[1-5-a]pirazin-8-ona como inhibidores de la fosfodiesterasa 9(pde9); y el uso de los mismos en el tratamiento de trastornos neurodegenerativos
|
|
US9271952B2
(en)
|
2011-10-11 |
2016-03-01 |
Complexa, Inc. |
Compositions and methods for treating nephropathy
|
|
DE102012008730A1
(de)
|
2011-12-02 |
2013-06-06 |
Dr. Budz GmbH |
Orale Zusammensetzungen mit ungesättigten C18-Fettsäuren und ihre Verwendung
|
|
EP2807163B1
(en)
*
|
2012-01-26 |
2017-03-22 |
H. Lundbeck A/S |
Pde9 inhibitors with imidazo triazinone backbone
|
|
JP6038184B2
(ja)
|
2012-02-01 |
2016-12-07 |
シティ・オブ・ホープＣｉｔｙ ｏｆ Ｈｏｐｅ |
リボヌクレオチドレダクターゼ阻害剤および使用方法
|
|
US10435367B2
(en)
|
2013-03-14 |
2019-10-08 |
City Of Hope |
Indirubin derivatives, and uses thereof
|
|
WO2013116753A1
(en)
|
2012-02-03 |
2013-08-08 |
University Of Pittsburgh-Of The Commonwelth System Of Higher Education |
Fatty acids as anti-inflammatory agents
|
|
EP2828262A4
(en)
|
2012-03-19 |
2015-09-23 |
Forum Pharmaceuticals Inc |
IMIDAZOTRIAZINONVERBINDUNGEN
|
|
US10058688B2
(en)
|
2012-05-09 |
2018-08-28 |
Massachusetts Institute Of Technology |
Medicament, method, and drug delivery device for treatment of ovarian cancer
|
|
SI2890384T1
(sl)
|
2012-08-31 |
2022-02-28 |
Taris Biomedical Llc |
Sistemi za dostavo zdravila in postopki za zdravljenje raka sečnega mehurja, ki obsegajo oksaliplatin
|
|
US20140271844A1
(en)
|
2013-03-15 |
2014-09-18 |
Nitromega Corp. |
Compositions containing nitro fatty acids
|
|
CA2944480C
(en)
|
2013-04-10 |
2021-05-18 |
Massachusetts Institute Of Technology |
Local drug delivery devices and methods for treating cancer
|
|
WO2014183108A1
(en)
|
2013-05-10 |
2014-11-13 |
Nitromega Corp. |
Nutritional or dietary supplements containing fatty acids and nitrite
|
|
WO2014204872A2
(en)
|
2013-06-14 |
2014-12-24 |
Complexa, Inc. |
Composition and method for inhibition of pkng from mycobacterium tuberculosis
|
|
WO2015023557A1
(en)
|
2013-08-12 |
2015-02-19 |
Nanomedical Systems, Inc. |
Device and method for sustained release of low water solubility therapeutic agent in solubilizer
|
|
WO2015073527A1
(en)
|
2013-11-12 |
2015-05-21 |
Complexa, Inc. |
Nitroalkene tocopherols and analogs thereof for use in the treatment and prevention of inflammation related conditions
|
|
WO2015185499A1
(en)
|
2014-06-06 |
2015-12-10 |
H. Lundbeck A/S |
Pde9 inhibitors with 1-benzyl-2,5,6,8-tetrahydro-3-oxo-2,7-naphthyridine-4-carbonitrile backbone
|
|
US10844064B2
(en)
|
2014-09-17 |
2020-11-24 |
Cyclerion Therapeutics, Inc. |
sGC stimulators
|
|
US20180092948A1
(en)
|
2015-04-02 |
2018-04-05 |
Aobiome Llc |
Production of nitro-fatty acids and nitro-hydrocarbons by ammonia oxidizing bacteria
|
|
CA2990521C
(en)
|
2015-07-07 |
2023-10-10 |
H. Lundbeck A/S |
Pde9 inhibitors with imidazo triazinone backbone and imidazo pyrazinone backbone for treatment of peripheral diseases
|
|
CN113440506A
(zh)
|
2015-10-02 |
2021-09-28 |
康普莱克夏公司 |
使用治疗有效量的活化脂肪酸预防、治疗和逆转疾病
|
|
WO2017141116A1
(en)
|
2016-02-19 |
2017-08-24 |
Phoenix Molecular Designs |
Carboxamide derivatives useful as rsk inhibitors
|
|
IL295973A
(en)
|
2016-07-06 |
2022-10-01 |
H Lundbeck As |
pde9 inhibitors for the treatment of peripheral diseases
|
|
HUE065158T2
(hu)
|
2017-05-26 |
2024-05-28 |
Cardurion Pharmaceuticals Inc |
PDE9 gátlószereinek elõállítására és alkalmazására szolgáló eljárások
|
|
BR112020024019A2
(pt)
|
2018-05-25 |
2021-02-23 |
Imara Inc. |
monoidrato e formas cristalinas de 6-[(3s,4s)-4-metil-1-(pirimidin-2-ilmetil)pirrolidin-3-il]-3-tetra-hidropiran-4-il-7h-imidazo[1,5-a]pirazin-8-ona
|
|
KR20250108770A
(ko)
|
2018-08-31 |
2025-07-15 |
카듀리온 파마슈티칼스, 인크. |
겸상 세포 질환의 치료를 위한 pde9 억제제
|
|
WO2020206336A1
(en)
|
2019-04-05 |
2020-10-08 |
Imara Inc. |
Pde9 inhibitors for treating sickle cell disease
|
|
CN114072151A
(zh)
|
2019-05-07 |
2022-02-18 |
伊马拉公司 |
用于治疗地中海贫血的pde9抑制剂
|
|
WO2022036111A1
(en)
|
2020-08-13 |
2022-02-17 |
Imara Inc. |
Methods and compositions for treating sickle cell disease
|
|
JP2023550269A
(ja)
|
2020-10-27 |
2023-12-01 |
カーデュリオン・ファーマシューティカルズ・インコーポレイテッド |
心不全を治療するためのｐｄｅ９阻害剤
|